Compare LEGN & AYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | AYA |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2020 | N/A |
| Metric | LEGN | AYA |
|---|---|---|
| Price | $19.87 | $26.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $45.62 | $31.49 |
| AVG Volume (30 Days) | ★ 2.0M | 990.7K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.73 | $121.85 |
| Revenue Next Year | $23.42 | $4.32 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $16.76 |
| 52 Week High | $37.50 | $30.67 |
| Indicator | LEGN | AYA |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 45.13 |
| Support Level | $19.71 | $25.40 |
| Resistance Level | $19.92 | $28.36 |
| Average True Range (ATR) | 0.82 | 0.95 |
| MACD | 0.14 | -0.23 |
| Stochastic Oscillator | 92.40 | 40.00 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.